Riskpilot← Back to searchSign inGet full accessProTreatment Slangerup ApS
APSActiveCVR 34225125Kongensgade 25APhysiotherapy activities · NACE 8695Est. 20123 employees
Revenue 2024
DKK 2,1M
+31% vs 2023
EBITDA margin
28.6%
-31% vs 2023
Equity ratio
50.9%
Financial strength
Net profit 2024
DKK 475K
-31% vs 2023
| Revenue | DKK 2,1M | +31% |
| EBITDA | DKK 613K | -31% |
| Net profit | DKK 475K | -31% |
| Total assets | DKK 1,3M | -12% |
| Equity | DKK 637K | -22% |
| Employees | 3 | — |
Legal name
ProTreatment Slangerup ApS
CVR number
34225125
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
1. februar 2012
Share capital
DKK 80.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller den samlede direktion.
Company purpose
Selskabets formål er at drive fysioterapeutvirksomhed samt hermed ligestillet virksomhed.
Address
Kongensgade 25A
Phone
+4547333638
Email
klinik@protreatment.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -929 | — | — | 1.317 | 1.087 | 1.522 | 1.545 | 1.712 | 1.201 | 1.443 | 1.429 | 1.642 | 2.148 |
| Staff expenses | -225 | -228 | -283 | -371 | -318 | -504 | -513 | -632 | -586 | -749 | -810 | -658 | -1.111 |
| EBITDA | 90 | 1.260 | 841 | 946 | 769 | 1.017 | 1.031 | 1.080 | 615 | 693 | 609 | 887 | 613 |
| Depreciation & amort. | -397 | -491 | -494 | -601 | -595 | -431 | -419 | -400 | -55 | -15 | -10 | -10 | -5 |
| EBIT | -307 | 769 | 347 | 346 | 175 | 586 | 612 | 680 | 560 | 678 | 599 | 877 | 608 |
| Net financials | -157 | -136 | -87 | -108 | -65 | -13 | -2 | -3 | 0 | -4 | -1 | 2 | 1 |
| Profit before tax | -150 | 633 | 260 | 237 | 110 | 573 | 610 | 677 | 560 | 675 | 598 | 879 | 609 |
| Tax | -38 | 158 | 63 | 57 | 25 | 127 | 135 | 147 | 123 | 148 | 132 | 193 | 134 |
| Net profit | -112 | 475 | 197 | 180 | 85 | 447 | 474 | 530 | 437 | 526 | 466 | 686 | 475 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | -3.380 | 2.913 | 2.730 | 2.607 | 1.952 | 1.496 | 1.298 | 1.343 | 1.343 | 1.391 | 1.266 | 1.421 | 1.252 |
| Equity | 192 | 667 | 364 | 545 | 629 | 526 | 563 | 623 | 534 | 631 | 577 | 813 | 637 |
| Long-term debt | -2.050 | 740 | 810 | 1.488 | 838 | 0 | 0 | 27 | 81 | 83 | 0 | 0 | 0 |
| Short-term debt | -1.114 | 1.486 | 1.519 | 542 | 468 | 936 | 690 | 693 | 728 | 678 | 689 | 609 | 615 |
| Total debt | -3.164 | 2.226 | 2.329 | 2.030 | 1.306 | 936 | 690 | 720 | 809 | 760 | 689 | 609 | 615 |
EBITDA margin
28.6%
This company
15.8%
Market median
+81% vs market
20122024
Equity ratio
50.9%
This company
38.2%
Market median
+33% vs market
20122024
Return on equity
74.5%
This company
18.4%
Market median
+305% vs market
20122024
Net profit margin
22.1%
This company
8.1%
Market median
+173% vs market
20122024
Asset turnover
1.72×
This company
1.12×
Market median
+54% vs market
20122024
Debt / equity
0.96×
This company
0.62×
Market median
+55% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-02-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NS Management | Management | 2018 | — | — |
TJ Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ProTreatment Holding ApS | Company | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ProTreatment Holding ApS
ProTreatment Slangerup ApS Board members of ProTreatment Slangerup ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nadia Seistrup | Management | 0 companies |
| Thomas Jørgensen | Chief Executive Officer | 0 companies |